184 related articles for article (PubMed ID: 4316248)
1. Specific role of each human leukocyte type in viral infections. I. Monocyte as host cell for vesicular stomatitis virus replication in vitro.
Edelman R; Wheelock EF
J Virol; 1967 Dec; 1(6):1139-49. PubMed ID: 4316248
[TBL] [Abstract][Full Text] [Related]
2. Specific role of each human leukocyte type in viral infections. II. Phytohemagglutinin-treated lymphocytes as host cells for vesicular stomatitis virus replication in vitro.
Edelman R; Wheelock EF
J Virol; 1968 May; 2(5):440-8. PubMed ID: 4301314
[TBL] [Abstract][Full Text] [Related]
3. Production of vesicular stomatitis virus with low infectivity by interferon-treated cells.
Maheshwari RK; Friedman RM
J Gen Virol; 1979 Jul; 44(1):261-4. PubMed ID: 227998
[TBL] [Abstract][Full Text] [Related]
4. Human fibroblast and leukocyte interferons show different dose-response curves in assay of cell protection.
Edy VG; Billiau A; De Somer P
J Gen Virol; 1976 May; 31(2):251-5. PubMed ID: 180244
[TBL] [Abstract][Full Text] [Related]
5. Cyclic AMP-mediated inhibition of vesicular stomatitis virus and herpes simplex virus replication in mouse macrophage-like cells.
Borghi P; Di Marzio P; Varano B; Conti L; Belardelli F; Gessani S
J Gen Virol; 1992 Nov; 73 ( Pt 11)():2949-54. PubMed ID: 1279103
[TBL] [Abstract][Full Text] [Related]
6. Reproduction of vaccinia virus (strain neurolapina) in rabbit blood leucocytes in vitro.
Benda R; Cinátl J; Plaisner V
J Hyg Epidemiol Microbiol Immunol; 1975; 19(1):93-104. PubMed ID: 165236
[TBL] [Abstract][Full Text] [Related]
7. Interferon-treated cells release vesicular stomatitis virus particles lacking glycoprotein spikes: correlation with biochemical data.
Maheshwari RK; Demsey AE; Mohanty SB; Friedman RM
Proc Natl Acad Sci U S A; 1980 Apr; 77(4):2284-7. PubMed ID: 6154948
[TBL] [Abstract][Full Text] [Related]
8. Selective inhibition of glycoprotein and membrane protein of vesicular stomatitis virus from interferon-treated cells.
Maheshwari RK; Jay FT; Friedman RM
Science; 1980 Feb; 207(4430):540-1. PubMed ID: 6243416
[TBL] [Abstract][Full Text] [Related]
9. Heterogeneity of the sensitivity of vesicular stomatitis virus to interferons.
Ito Y; Montagnier L
Infect Immun; 1977 Oct; 18(1):23-7. PubMed ID: 198374
[TBL] [Abstract][Full Text] [Related]
10. Sensitivity of ribonucleic acid and deoxyribonucleic acid viruses to different species of interferon in cell cultures.
Youngner JS; Thacore HR; Kelly ME
J Virol; 1972 Aug; 10(2):171-8. PubMed ID: 4342236
[TBL] [Abstract][Full Text] [Related]
11. Selective induction of the monocyte-attracting chemokines MCP-1 and IP-10 in vesicular stomatitis virus-infected human monocytes.
Bussfeld D; Nain M; Hofmann P; Gemsa D; Sprenger H
J Interferon Cytokine Res; 2000 Jul; 20(7):615-21. PubMed ID: 10926203
[TBL] [Abstract][Full Text] [Related]
12. [On the joint effect of interferon and histone on the cytopathic effect of vesicular stomatitis virus].
Balandin IG; Diuĭsalieva RG; Kol'tsov VD; Lushnikov AA
Vopr Virusol; 1968; 13(5):630. PubMed ID: 4303598
[No Abstract] [Full Text] [Related]
13. Quantification of the antiviral effect of interferon by immunoassay of vesicular stomatitis virus proteins.
Wallach D
J Gen Virol; 1983 Oct; 64 (Pt 10)():2221-7. PubMed ID: 6194250
[TBL] [Abstract][Full Text] [Related]
14. Effect of exogenous tumor necrosis factor alpha, interleukin 6 and interferons on vesicular stomatitis virus replication in human placenta and amniotic membrane organ cultures.
Paradowska E; Blach-Olszewska Z; Gierlińska M; Woytoń J
Arch Immunol Ther Exp (Warsz); 1996; 44(1):57-62. PubMed ID: 8874771
[TBL] [Abstract][Full Text] [Related]
15. In vivo administration of tumor necrosis factor-alpha is associated with antiviral activity in human peripheral mononuclear cells.
Nokta M; Matzke D; Jennings M; Schlick E; Nadler PI; Pollard R
Proc Soc Exp Biol Med; 1991 Jun; 197(2):144-9. PubMed ID: 1709503
[TBL] [Abstract][Full Text] [Related]
16. Production of interferon by long-term suspension cultures of leukocytes derived from patients with viral and nonviral diseases.
Minnefor AB; Halsted CC; Seto DS; Glade PR; Moore GE; Carver DH
J Infect Dis; 1970 Apr; 121(4):442-4. PubMed ID: 4315000
[No Abstract] [Full Text] [Related]
17. Functional and ultrastructural studies of the effects of human interferon on cell membranes of in vitro cultured cells.
Degré M; Hovig T
Acta Pathol Microbiol Scand B; 1976 Dec; 84B(6):347-58. PubMed ID: 187008
[TBL] [Abstract][Full Text] [Related]
18. Variable deficiencies in the interferon response enhance susceptibility to vesicular stomatitis virus oncolytic actions in glioblastoma cells but not in normal human glial cells.
Wollmann G; Robek MD; van den Pol AN
J Virol; 2007 Feb; 81(3):1479-91. PubMed ID: 17108037
[TBL] [Abstract][Full Text] [Related]
19. Replication and cytopathic effect of oncolytic vesicular stomatitis virus in hypoxic tumor cells in vitro and in vivo.
Connor JH; Naczki C; Koumenis C; Lyles DS
J Virol; 2004 Sep; 78(17):8960-70. PubMed ID: 15308693
[TBL] [Abstract][Full Text] [Related]
20. Persistence of vesicular stomatitis virus in interferon-treated cell cultures.
Thacore HR; Youngner JS
Virology; 1975 Feb; 63(2):345-51. PubMed ID: 163524
[No Abstract] [Full Text] [Related]
[Next] [New Search]
